Diabetes drug safety trial ends early, no results yet
NCT ID NCT06143423
First seen Apr 28, 2026 · Last updated Jun 10, 2026 · Updated 8 times
Summary
This early-stage study tested the safety of a new drug called AP026 in healthy adults. The trial was stopped early and only 14 people took part instead of the planned 74. The main goal was to check for side effects, not to see if the drug works for diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The first hospital of Jilin University
Changchun, Jilin, 130061, China
Conditions
Explore the condition pages connected to this study.